Effects of GLP-1 receptor agonists on kidney and cardiovascular disease outcomes: a meta-analysis of randomised controlled trials
Sunil V. Badve, Anika Bilal, Matthew M.Y. Lee, Naveed Sattar, Hertzel C. Gerstein, Christian T. Ruff, John J.V. McMurray, Peter Rossing, George Bakris, Kenneth W. Mahaffey, Johannes F.E. Mann, Helen M. Colhoun, Katherine R Tuttle, Richard E. Pratley, Vlado Perkovic
Topics & Concepts
MedicineMeta-analysisGlucagon-like peptide 1 receptorRandomized controlled trialMEDLINESemaglutideInternal medicineType 2 diabetesDiseaseDiabetes mellitusIntensive care medicineLiraglutideAgonistEndocrinologyReceptorLawPolitical scienceDiabetes Treatment and ManagementChronic Kidney Disease and DiabetesHyperglycemia and glycemic control in critically ill and hospitalized patients